CDC: 10 allergic reactions have been reported after Modena's new crown vaccination

　　Xinhua News Agency, Washington, January 22 (Reporter Tan Jingjing) A report issued by the Centers for Disease Control and Prevention on the 22nd showed that as of January 10, a total of 4,041,396 people in the U.S. had received the first dose of the drug developed by Modena. The new crown vaccine has reported 1,266 adverse events (adverse reaction rate is about 0.03%), including 10 allergic reactions.

　　The US Food and Drug Administration approved an emergency use authorization application for Modena's new crown vaccine on December 18 last year.

This is the second new crown vaccine approved for emergency use in the United States after the new crown vaccine jointly developed by Pfizer Pharmaceuticals Co., Ltd. of the United States and the German Biotech Company. It is allowed to be used for people aged 18 and over. A total of two doses are administered with an interval of 1 Months.

　　According to the US Centers for Disease Control and Prevention, allergic reactions are serious life-threatening adverse reactions that usually occur within a few minutes to a few hours after vaccination, with a small probability of occurrence.

As of January 10, of the 1,266 adverse events reported after vaccination with Modena vaccine, 10 were confirmed as allergic reactions, of which 9 occurred within 15 minutes after vaccination, and 1 occurred within 45 minutes after vaccination; 108 possible serious adverse events, including allergic reactions, need further verification.

No deaths related to allergic reactions have been reported.

　　Previously, the US Centers for Disease Control and Prevention reported that as of December 23, 2020, a total of 1,893,360 people in the United States had received the first dose of Pfizer's new crown vaccine, and a total of 4,393 adverse events were reported, including 21 allergic reactions.

　　The US Centers for Disease Control and Prevention reports that the new crown vaccination sites need to strictly follow the relevant requirements of the US Centers for Disease Control and Prevention for new crown vaccination, including screening for vaccination contraindications, making necessary preparations for allergic reactions, and observing the situation of vaccinators after vaccination, etc. .

　　According to vaccine data on the US Centers for Disease Control and Prevention website, as of January 22, more than 39.89 million doses of the new crown vaccine have been distributed across the United States, and more than 19.1 million doses have been vaccinated.